Gerd Dipl Chem Dr Hilboll

Omega-[(omega-arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors.

Triphenylimidazolyloxyalkanoic acids and their derivatives and a process for the treatment of thromboembolic, inflammatory and/or atheriosclerotic diseases

New 5-(omega-arylalkyl)-2-thienyl alkanoic acid derivs. as LTB inhibitors - for treating eczema, psoriasis, acne, arthritis, asthma, rhinitis and inflammatory skin disorders

IMIDAZOLYLALKYLTHIENYL-TETRAHYDROPYRIDAZINES AND PROCESS FOR THEIR PREPARATION

Omega-[(omega-arylalkyl)thienyl]alkanoic acids: from specific LTA4 hydrolase inhibitors to LTB4 receptor antagonists.

Imidazolylalkylthienyl tetrahydropyridazines and processes for their use

Method of treating high blood pressure using 6-[4-(1-imidazolyl)-phenyl]-5-methyl-3-oxo-tetrahydropyridazines

6-{5-[ω-(1-Imidazolyl)-alkyl] -thien-2-yl}-3-oxo-2,3,4,5-tetrahydro-pyridazines and acid addition salts thereof and a process for the treatment of inflammatory atherosclerotic and thrombo-embolic, illnesses in humans

TRIPHENYLIMIDAZOLYLOXYALCANOIC ACIDS AND THEIR DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them